Clinical trials: SARCOIDOSIS
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis
Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease
Interstitial lung disease (ILD) is a restrictive lung disease characterized by impaired lung function, exercise limitation and skeletal muscle dysfunction.
- Conditions
- Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Sarcoidosis, Pulmonary, Geriatric
- Trial name
- NCT04803617
- Testing
- Assessment of pulmonary function and pectoralis muscle strength
- Where
- Turkey (Türkiye)
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Habibedurdu
Sarcoidosis, Pulmonary Arterial Hypertension
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
This trial will study the treatment of sarcoidosis-associated pulmonary arterial hypertension with inhaled iloprost, a drug approved for primary pulmonary arterial hypertension.
- Trial name
- NCT00403650
- Testing
- Iloprost
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Cincinnati
Cardiac Sarcoidosis
Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis
What is the purpose of this research? This study includes two parts based in two NHS specialist centres for cardiac sarcoidosis: Development of the CARD-SARC: Development of the new questionnaire to measure quality of life in…
- Trial name
- NCT05145023
- Where
- 2 sites in United Kingdom
- Volunteers
- 130 people
- Sponsor
- Queen Mary University of London
Sarcoidosis
A Phase 2 Study With CC-220 in Skin Sarcoidosis
This study will evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of oral CC-220 in adult subjects with chronic cutaneous sarcoidosis.
- Trial name
- NCT02192489
- Testing
- CC-220 0.3 mg Daily, CC-220 0.6mg Daily
- Sponsor
- Celgene
Pulmonary Sarcoidosis
Rehabilitation in Pulmonary Sarcoidosis: a Prospective Study
Sarcoidosis is a heterogeneous multisystem disorder of unknown etiology which often presents with bilateral hilar lymphadenopathy, pulmonary infiltration and ocular and skin lesions.
- Trial name
- NCT01384123
- Where
- Israel
- Volunteers
- 50 people
- Sponsor
- Meir Medical Center
SARS-CoV Infection, Systemic Disease
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
An observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease…
- Conditions
- SARS-CoV Infection, Systemic Disease, Systemic Lupus Erythematosus, Sjogren's Syndrome
- Trial name
- NCT04530461
- Testing
- Serological test
- Where
- Tunisia
- Volunteers
- 200 people
- Sponsor
- faida agili
Cutaneous Sarcoidosis, Granuloma Annulare
Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
To investigate the ability of tofacitinib, a Janus kinase (JAK) inhibitor, to treat patients with cutaneous sarcoidosis and granuloma annulare during 6 months of therapy.
- Trial name
- NCT03910543
- Testing
- Tofacitinib 5 mg twice daily
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Yale University
Sarcoidosis, Lymphoma
Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma
The guided FNA by endobronchial ultrasound ( Endobronchial Ultrasound guided transbronchial Needle Aspiration or EBUS-TBNA) is a minimally invasive technique with an established role in the staging of lung cancer 1, and in the…
- Conditions
- Sarcoidosis, Lymphoma, Adenopathy Hilar
- Trial name
- NCT03573362
- Testing
- ViziShot FLEX 19G needle, Vizishot 22G needle (standard)
- Where
- Canada
- Volunteers
- 50 people
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
Sarcoidosis, Endosonography
EBUS vs EUS-B for Diagnosing Sarcoidosis
Rationale: Endosonography with mediastinal/ hilar nodal sampling is the test of choice to diagnose sarcoidosis stage I and II - in case tissue verification of noncaseating granulomas is indicated.
- Trial name
- NCT02540694
- Testing
- Endosonography
- Where
- Netherlands
- Volunteers
- 350 people
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Heart Disease Structural Disorder, Ventricular Tachycardia
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
Sudden cardiac death (SCD) due to recurrent ventricular tachycardia (VT) is an important clinical sequela in patients with structural heart disease.
- Conditions
- Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated, Sarcoidosis
- Trial name
- CAAD-VT (NCT05524077)
- Testing
- Ablation, Anti-arrhythmic Drugs (AADs)
- Where
- 9 sites in Australia
- Volunteers
- 162 people
- Sponsor
- Western Sydney Local Health District
Sarcoidosis
Rituximab for Pulmonary Sarcoidosis
Sarcoidosis is a inflammatory disease affecting many parts of the body, especially the lungs. While most patients do well, there is a group of patients who require continuous doses of prednisone or other drugs.
- Trial name
- RIPS (NCT00855205)
- Testing
- Rituximab
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Cincinnati
Sarcoidosis
Chronic Fatigue in Sarcoidosis
Background: Chronic fatigue (CF) is a prominent symptom in many sarcoidosis patients, affecting quality of life (QoL) and interfering with treatment.
- Trial name
- NCT04178239
- Testing
- fMRI, questionnaires, pneumologic diagnostics
- Where
- Germany
- Volunteers
- 31 people
- Sponsor
- RWTH Aachen University
Sarcoidosis, Influenza Vaccine
Efficacy and Safety of Influenza Vaccine During Sarcoidosis
Sarcoidosis is an inflammatory disease of unknown origin that can affect all organs, especially the lungs and mediastinum. Some location of sarcoidosis may require treatment with corticosteroids or immunosuppressors.Although…
- Trial name
- SARCOVAC (NCT01687517)
- Testing
- Seasonal influenza vaccine available for the 2012-2013 vaccine campaign
- Where
- France
- Volunteers
- 190 people, healthy volunteers welcome
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Neoplasms, Infection
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques
The aim of this study is to compare endoscopic ultrasound guided-fine needle aspiration (EUS-FNA) with a standard 22-gauge needle using "standard suction", "slow-pull" and "wet suction" for thoracic/abdominal solid/solid-cystic…
- Conditions
- Neoplasms, Infection, Inflammation, Lymphoma
- Trial name
- EUS-FNA (NCT03674710)
- Testing
- Standard suction, slow-pull, wet suction, Standard suction, wet suction, slow-pull, Slow-pull, standard suction, wet suction
- Where
- 4 sites in China
- Volunteers
- 300 people
- Sponsor
- Shanghai Zhongshan Hospital
Uveitis Tuberculous, Uveitis Sarcoid
Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)
Today there are no tests that allow to make a precise differential diagnosis between uveitis from presumed tuberculous origin and uveitis by sarcoidosis.
- Trial name
- TBC-SARC (NCT03346018)
- Testing
- Analysis of aqueous humor and plasma samples
- Where
- Italy
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
Stage 4 Pulmonary Sarcoidosis
Pulmonary Rehabilitation in Patients With Sarcoidosis
The primary objective of the study is to assess the improvement of daily activity in subjects with Stage IV Pulmonary Sarcoidosis one year after the conduct of a pulmonary rehabilitation program.
- Trial name
- NCT02044939
- Testing
- Pulmonary rehabilitation program
- Where
- 11 sites in France
- Volunteers
- 38 people
- Sponsor
- University Hospital, Lille
Sarcoidosis Lung
Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development
Impact of Immunosuppressive Therapy for Sarcoidosis on Lymphoma Development
- Trial name
- NCT07343401
- Testing
- lymph node biopsy
- Where
- Egypt
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Alexandria University
Sarcoidosis
Riociguat for Sarcoidosis Associated Pulmonary Hypertension
Double blind placebo controlled trial of riociguat for sarcoidosis associated pulmonary hypertension
- Trial name
- RioSAPH (NCT02625558)
- Testing
- Riociguat
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- University of Cincinnati
Sarcoidosis
SARCOTHAL. Thalidomide in Skin Sarcoidosis
Sarcoidosis is a multisystem disease involving most frequently the lung, the eyes, the lymph nodes and the skin. Skin lesions may be disfiguring and impair the quality of life.
- Trial name
- NCT00305552
- Testing
- THALIDOMIDE
- Where
- France
- Volunteers
- 40 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Sarcoidosis; Antimycobacterial Therapy
Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis
The primary purpose of this study is to investigate the efficacy and safety of oral antimycobacterial therapy in patients with confirmed progressive pulmonary sarcoidosis.
- Trial name
- NCT02024555
- Testing
- Levofloxacin, Ethambutol, Azithromycin
- Where
- 6 sites in United States
- Volunteers
- 97 people
- Sponsor
- Vanderbilt University